I think the impairments probably relate more to accounting treatment. Although I am no expert of accounting rules I believe there would be an impact on holding R&D expenditure for example as an asset on your balance sheet if the likelihood of receiving revenue moved from 2 years to 6 years. I wouldn't read too much into the impairment as I believe it would be accounting rule related to the delay.
i am the iceman!
cameco Q2, page-3
Add SLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.16 |
Change
-0.090(1.71%) |
Mkt cap ! $1.224B | |||
| Open | High | Low | Value | Volume |
| $5.23 | $5.23 | $5.03 | $1.976M | 385.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 455 | $5.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.17 | 1306 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SLX (ASX) Chart |